Atlas Infectious Disease Practice

Welcome to Atlas Infectious Disease Practice, where your health and the well-being of the community are our top priorities. We take pride in our critical role in safeguarding public health by providing a comprehensive range of services focused on the diagnosis, treatment, management, and prevention of infectious diseases. Our dedicated team of physicians and healthcare professionals are committed to delivering expert care and guidance. Explore the services and affiliations that make us a trusted partner in your health journey

Mission Statement

At Atlas Infectious Disease Practice, we are dedicated to providing exceptional and compassionate care for patients in Palm Beach County and the surrounding areas. Our practice specializes in treating a wide range of infectious diseases, including HIV, tuberculosis, hepatitis, sexually transmitted infections, respiratory illnesses, and more.

As the leading infectious disease doctors near you, we utilize cutting-edge diagnostics and innovative treatments to enhance health outcomes and improve the quality of life for our patients. Our holistic approach focuses not only on treating current infections but also on preventing future ones. We are committed to personalized care, providing education and empowering our patients to actively manage their health.

Conveniently located in Palm Beach County, Atlas Infectious Disease Practice is your trusted partner in managing infectious diseases. Whether you’re seeking proactive Prevention or expert care from the best Infectious Disease Doctors near you, our team is here to help.

.

Services

Services Provided

Hospital Consultation

Office Consultation

Immigration Exams

Travel Consultation

Telemedicine

Yellow Fever Vaccine

HIV medicine

Sexually transmitted infection

employee health

IV infusion

Latest news

Stay Informed

FDA Requests Additional Trial of Novavax NVX-CoV2601 Vaccine Prior to Approval

Robert Walker, MD (Credit: Novavax) The FDA has requested that Novavax complete an additional clinical trial for its COVID-19 vaccine, NVX-CoV2601, which it is seeking full approval for after it was...

Targeting Apicoplast, Key to Malaria Transmission Across Hosts

A recent breakthrough from the Indiana University School of Medicine offers new hope for fast-acting antimalarial treatments that could target the malaria parasite across multiple life stages. Led by...

Targeting Apicoplast in All Stages of Malaria Parasite May Prevent Infection Across Hosts

A recent breakthrough from the Indiana University School of Medicine offers new hope for fast-acting antimalarial treatments that could target the malaria parasite across multiple life stages. Led by...

Persistent Barriers and Emerging Threats in Malaria Control

For World Malaria Day, we spoke with Andrew Lover, PhD, MPH, MS, associate professor of epidemiology at the University of Massachusetts Amherst and deputy director of the CDC-sponsored New England...

Decoding Malaria Parasites to Aid in Potential Treatments and Vaccines

Malaria mostly spreads to people through the bites of infected female Anopheles mosquitoes. Blood transfusion and contaminated needles can also transmit malaria.1 There are 5 Plasmodium parasite...

Targeting PfAnchor Halts Malaria Parasite Growth in One Cycle

Researchers at Indiana University School of Medicine have identified a protein that plays a critical role in the survival of Plasmodium falciparum, the parasite that causes the most lethal form of...

CIDRAP Launches its Vaccine Integrity Project

Today, CIDRAP announced it is launching its Vaccine Integrity Project, which is an initiative that is designed to safeguard vaccine use in the US. It has a steering committee that will engage...

New Transgenic Rhesus Macaque Model Paves Way for HBV Therapy Development

Ben Burwitz, PhD Image credits: LinkedIn Scientists have created the first transgenic nonhuman primate model susceptible to hepatitis B virus (HBV), potentially enabling preclinical testing of...

HCV Combination Therapy Meets Phase 2 Endpoints, Will Present Data at Conference

Image Credit: Atea Pharmaceuticals Atea Pharmaceuticals is going to provide its full phase 2 data, which will show it met its primary endpoints at the upcoming EASL Congress in May. It will present...

Mathematical Model Highlights Challenges in Combating Hepatitis B in Nigeria

Hepatitis B blood test. Image credits: Unplash A study published in Scientific Reports has developed a mathematical model of hepatitis B virus (HBV) transmission using integer and fractional calculus...

Alcohol Use Disorder Among Individuals Who Take HIV PrEP

This cohort study analyzes the prevalence of alcohol use disorder (AUD) diagnoses among commercially...

Cuts to HIV Assistance Could Undo Years of Progress

Since 2015, global foreign aid has provided nearly 40% of HIV-related funding in low- and...

Experts Say CDC Cuts Will Cost Lives

This Medical News article discusses how recent workforce and program reductions at the US Centers...

Testing the Boundaries of Presidential Powers in Health

This Viewpoint discusses the unprecedented assertion of presidential control over federal spending...

Variability in Primary Care Telehealth Delivery Methods Across Chronic Conditions

This cross-sectional study examines chronic conditions that are more or less likely to be managed in...

HIV Viral Suppression With Long-Acting Antiretroviral Therapy

This study uses electronic medical record data to compare 48-week viral load outcomes after starting...

Unintentional Fentanyl Use Detected in Hair

This study assessed hair samples to detect fentanyl exposure among people with or at risk of HIV...

Comparative Bleeding Risk in Older Patients With HIV and Atrial Fibrillation Receiving Oral Anticoagulants

This cohort study compares the bleeding risks among warfarin, rivaroxaban, and apixaban users in a...

Hepatitis C Virus Screening in Pregnant and Nonpregnant Women After Universal Screening Guidelines

This study examines whether hepatitis C virus screening differs among pregnant and nonpregnant...

Early Release – The Oldest Art – Volume 31, Number 5—May 2025 – Emerging Infectious Diseases journal

Disclaimer: Early release articles are not considered as final versions. Any changes will be...

Accepted insurances

Schedule appointment

We Are Dedicated To Your Health!

Better Care Starts With Us!

Testimonials

What Our Patients Say About Us!